What does BeMedico do?

BeMedico is a wholesaler in Herzele. Public Limited, started on 9 December 1987, 1 establishment.

What is the address of BeMedico?

The registered office of BeMedico is located at Mutsaardstraat 47, 9550 Herzele.

Is BeMedico still active?

Yes. According to the CBE (29 October 2026) BeMedico is active, legal situation “Normale toestand”, started on 9 December 1987.

Is BeMedico registered on Peppol?

Yes, BeMedico is registered on the Peppol network with ID 0208:0432727589.

What is the enterprise number of BeMedico?

The enterprise number of BeMedico is BE0432727589.

When was BeMedico founded?

BeMedico was founded on 9 December 1987.

Who are the directors of BeMedico?

According to the 2025 annual accounts, the directors of BeMedico are: Medical Holding BV, GLOREN BV, MicroMatic BV.

Is BeMedico a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 December 1987; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did BeMedico make in 2025?

BeMedico posted a profit after taxes of € 954,002 in financial year 2025.

What is the revenue of BeMedico?

In its most recent annual accounts (2025), BeMedico reported revenue of € 17,368,443.

How much does an employee at BeMedico earn?

The average wage cost per full-time employee at BeMedico was € 106,300 in 2025: staff costs of € 1.6 million for 14.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does BeMedico have?

According to the 2025 annual accounts, BeMedico has 14.6 full-time equivalents (FTE).

BeMedico (Public Limited) - Herzele - BE0432727589

Dossier BeMedico, printed on 29 October 2026 from databakkes.be/en/0432727589/bemedico. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

BeMedico from Herzele, company number BE0432727589, closed financial year 2025 with a result of € 954,002 after tax. For that financial year BeMedico recorded revenue of € 17.4 million and equity of € 6.8 million. Compared with financial year 2024, the result moved from € 1 million to € 954,002. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Growing

€ 6.8 million

▲ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 954,002

▼ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 255,009

▲ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 129,000 paid out

14 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

14.6

▲ 1.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 4.4 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 1.6 million

▲ 22% vs 2024

€ 106,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 100,125

▼ 47% vs 2024

Of which on lease € 36,438.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 967,958

▼ 29% vs 2024

€ 417,844 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 1.5 million

▼ 30% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 40 days on average.

Taxes and wages

€ 301,853

▼ 13% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 14,245,789 Revenue 2022: € 14,245,789 First fiscal year in the series	€ 14,476,650 Revenue 2023: € 14,476,650 ▲ 2% vs 2022 (€ 14,245,789) Favourable step	€ 16,397,339 Revenue 2024: € 16,397,339 ▲ 13% vs 2023 (€ 14,476,650) Favourable step	€ 17,368,443 Revenue 2025: € 17,368,443 ▲ 6% vs 2024 (€ 16,397,339) Favourable step	▲ 6%
Profit after taxes	€ -1,108,305 Profit after taxes 2022: € -1,108,305 First fiscal year in the series	€ -1,008,152 Profit after taxes 2023: € -1,008,152 ▲ € 100,154 vs 2022 (€ -1,108,305) Favourable step	€ 1,023,030 Profit after taxes 2024: € 1,023,030 ▲ € 2 million vs 2023 (€ -1,008,152) Favourable step	€ 954,002 Profit after taxes 2025: € 954,002 ▼ 7% vs 2024 (€ 1,023,030) Unfavourable step	▼ 7%
Equity	€ 9,220,479 Equity 2022: € 9,220,479 First fiscal year in the series	€ 6,442,199 Equity 2023: € 6,442,199 ▼ 30% vs 2022 (€ 9,220,479) Unfavourable step	€ 6,014,373 Equity 2024: € 6,014,373 ▼ 7% vs 2023 (€ 6,442,199) Unfavourable step	€ 6,839,375 Equity 2025: € 6,839,375 ▲ 14% vs 2024 (€ 6,014,373) Favourable step	▲ 14%
Total debts	€ 4,355,738 Total debts 2022: € 4,355,738 First fiscal year in the series	€ 3,629,796 Total debts 2023: € 3,629,796 ▼ 17% vs 2022 (€ 4,355,738) Favourable step	€ 4,626,616 Total debts 2024: € 4,626,616 ▲ 27% vs 2023 (€ 3,629,796) Unfavourable step	€ 3,495,535 Total debts 2025: € 3,495,535 ▼ 24% vs 2024 (€ 4,626,616) Favourable step	▼ 24%
Cash	€ 1,042,099 Cash 2022: € 1,042,099 First fiscal year in the series	€ 222,435 Cash 2023: € 222,435 ▼ 79% vs 2022 (€ 1,042,099) Unfavourable step	€ 251,906 Cash 2024: € 251,906 ▲ 13% vs 2023 (€ 222,435) Favourable step	€ 255,009 Cash 2025: € 255,009 ▲ 1% vs 2024 (€ 251,906) Favourable step	▲ 1%
Land & buildings	€ 507 Land & buildings 2022: € 507 First fiscal year in the series	€ 0 Land & buildings 2023: € 0 ▼ 100% vs 2022 (€ 507) Unchanged	-	€ 0 Land & buildings 2025: € 0 First fiscal year in the series
Retained profit	€ 4,057,837 Retained profit 2022: € 4,057,837 First fiscal year in the series	€ 1,279,556 Retained profit 2023: € 1,279,556 ▼ 68% vs 2022 (€ 4,057,837) Unfavourable step	€ 851,730 Retained profit 2024: € 851,730 ▼ 33% vs 2023 (€ 1,279,556) Unfavourable step	€ 1,676,733 Retained profit 2025: € 1,676,733 ▲ 97% vs 2024 (€ 851,730) Favourable step	▲ 97%
Dividend	€ 600,000 Dividend 2022: € 600,000 First fiscal year in the series	€ 1,770,129 Dividend 2023: € 1,770,129 ▲ 195% vs 2022 (€ 600,000) Unchanged	€ 1,450,857 Dividend 2024: € 1,450,857 ▼ 18% vs 2023 (€ 1,770,129) Unchanged	€ 129,000 Dividend 2025: € 129,000 ▼ 91% vs 2024 (€ 1,450,857) Unchanged	▼ 91%
Bank debt	€ 330,097 Bank debt 2022: € 330,097 First fiscal year in the series	€ 1,129,632 Bank debt 2023: € 1,129,632 ▲ 242% vs 2022 (€ 330,097) Unfavourable step	€ 1,368,241 Bank debt 2024: € 1,368,241 ▲ 21% vs 2023 (€ 1,129,632) Unfavourable step	€ 967,958 Bank debt 2025: € 967,958 ▼ 29% vs 2024 (€ 1,368,241) Favourable step	▼ 29%
Balance sheet total	€ 13,576,217 Balance sheet total 2022: € 13,576,217 First fiscal year in the series	€ 10,071,995 Balance sheet total 2023: € 10,071,995 ▼ 26% vs 2022 (€ 13,576,217) Unchanged	€ 10,640,989 Balance sheet total 2024: € 10,640,989 ▲ 6% vs 2023 (€ 10,071,995) Unchanged	€ 10,334,910 Balance sheet total 2025: € 10,334,910 ▼ 3% vs 2024 (€ 10,640,989) Unchanged	▼ 3%
Employees (FTE)	13.1 Employees (FTE) 2022: 13.1 First fiscal year in the series	14 Employees (FTE) 2023: 14 ▲ 0.9 vs 2022 (13.1) Unchanged	13 Employees (FTE) 2024: 13 ▼ 1 vs 2023 (14) Unchanged	14.6 Employees (FTE) 2025: 14.6 ▲ 1.6 vs 2024 (13) Unchanged	▲ 1.6

Key figures of BeMedico, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BeMedico?

What happened at BeMedico in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2032 Medical Holding BV stepped down as director. NBB
2032 GLOREN BV stepped down as director. NBB
2032 MicroMatic BV stepped down as director. NBB
Aug 28, 2026 New annual accounts for financial year 2025: profit of € 954,002 (▼ 7% vs 2024). filed late Source: NBB ↗
2026 Medical Holding BV became a director. NBB
2026 GLOREN BV became a director. NBB
2026 MicroMatic BV became a director. NBB
Dec 18, 1987 New establishment in Herzele. KBO

In short

From € 1.1 million loss in 2022 to € 954,002 profit in 2025.

Paid € 1.3 million in corporate taxes since 2022.

Best year ever: 2024, with € 1 million profit.

Paid out € 3.9 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

GLOREN 10%

The stake of GLOREN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

BeMedico

SBI 100%

The shares are held by GLOREN (10%). It owns 100% of SBI itself.

Directors

According to the 2025 annual accounts

Medical Holding BV

Director · represented by Filip KNEZ

Also active at: ACCURAMED, B &C° GROUP SERVICES, SMARTBLEACH INTERNATIONAL

since 2026 · until 2032

GLOREN BV

Director · represented by Dominique SOETAERT

Also active at: B &C° GROUP SERVICES, SMARTBLEACH INTERNATIONAL

since 2026 · until 2032

MicroMatic BV

Director · represented by Karel KNEZ

Also active at: ACCURAMED, B &C° GROUP SERVICES, MediConsult, SMARTBLEACH INTERNATIONAL, Medical Holding

since 2026 · until 2032

Shareholders

GLOREN

10%

Participations

SBI

100%

Establishments

Establishment units

Physical locations of this company

Registered office

Mutsaardstraat 47

9550 Herzele

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

B &C° GROUP SERVICES same network

€ 1.4 million gross margin · 2025

SMARTBLEACH INTERNATIONAL same network

€ -17,657 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0432.727.589

VAT number

BE 0432.727.589

Registered office

Mutsaardstraat 47, 9550 Herzele

Names & denominations

BeMedico

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

9 December 1987

Peppol

Active · Active since 22 Oct 2025

Activities · NACE

Groothandel in farmaceutische en medische artikelen

Groothandel in farmaceutische producten

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

Detailhandel in huishoudtextiel en beddengoed

Detailhandel in overige sportartikelen

Detailhandel in textiel

View on CBE Public ↗ Annual accounts (NBB) ↗

BeMedico

Financials

What happened to BeMedico?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions